Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs. (Q45953907)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 June 2009

Language	Label	Description	Also known as
English	Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.	scientific article published on 22 June 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Silvia Pérez-Silanes

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Mercedes Gonzalez

12

object named as

Mercedes González

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

author name string

Saioa Ancizu

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Elsa Moreno

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Enrique Torres

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Asunción Burguete

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Diego Benítez

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Raquel Villar

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Beatriz Solano

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Adoración Marín

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Ignacio Aldana

10

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Hugo Cerecetto

11

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

Antonio Monge

13

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

language of work or name

0 references

publication date

22 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

14

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

2256-2272

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

copyright license

Creative Commons Attribution 4.0 International

22 June 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Chemotherapy of Chagas' disease: status and new developments

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pyrimido[1,2-a]quinoxaline 6-oxide and phenazine 5,10-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Study of 5-nitroindazoles' anti-Trypanosoma cruzi mode of action: electrochemical behaviour and ESR spectroscopic studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Mycobacterium tuberculosis agents derived from quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QSAR analysis for quinoxaline-2-carboxylate 1,4-di-N-oxides as anti-mycobacterial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Substitutions of fluorine atoms and phenoxy groups in the synthesis of quinoxaline 1,4-di-N-oxide derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo anti-Chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-T. cruzi agents: our experience in the evaluation of more than five hundred compounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quinoxaline N,N'-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-Oxide derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/19553897

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3390/MOLECULES14062256

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19553897

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45953907&oldid=2207710692"